What tetanus prophylaxis (tetanus toxoid vaccine and tetanus immune globulin) should be given for a dirty (contaminated) wound based on the patient’s immunization history?

Tetanus Prophylaxis for Dirty Wounds

For dirty wounds, administer tetanus toxoid (Tdap preferred) if ≥5 years have passed since the last dose in patients with ≥3 documented lifetime doses; give BOTH tetanus toxoid AND tetanus immune globulin (TIG) 250 units IM at separate sites for patients with <3 doses or unknown vaccination history. 1, 2

Wound Classification Determines the Critical Time Interval

• Dirty/contaminated wounds require a 5-year interval for booster consideration, not the 10-year interval used for clean, minor wounds 1, 3
• Contaminated wounds include those exposed to dirt, feces, soil, saliva, puncture wounds, avulsions, and wounds from missiles, crushing, burns, or frostbite 1
• This classification is critical because it determines whether you use the 5-year or 10-year threshold for tetanus toxoid administration 3

Decision Algorithm Based on Vaccination History

Patients with ≥3 Documented Lifetime Doses (Complete Primary Series)

If last dose was <5 years ago:

• No tetanus toxoid needed 1, 2
• No TIG needed 1, 2
• The patient is already protected 1

If last dose was ≥5 years ago:

• Give tetanus toxoid-containing vaccine (Tdap strongly preferred if never received Tdap or Tdap history unknown) 1, 3, 2
• No TIG needed because the complete primary series provides the foundation for rapid antibody response after booster 1, 2
• For non-pregnant patients with documented prior Tdap, either Td or Tdap may be used 1

Patients with <3 Documented Doses or Unknown/Uncertain History

• Treat unknown or uncertain vaccination history as zero prior doses 1, 4, 2
• Give BOTH tetanus toxoid-containing vaccine (Tdap preferred) AND TIG 250 units IM 1, 4, 2
• Administer using separate syringes at different anatomical sites (e.g., deltoid and lateral thigh) to prevent interference with immune response 1, 2
• The gluteal region should not be used due to risk of sciatic nerve injury 2
• Complete the 3-dose primary series: second dose ≥4 weeks later, third dose 6-12 months after the second 1

Why Tdap Over Td

• Tdap is strongly preferred over Td for persons ≥11 years who have not previously received Tdap or whose Tdap history is unknown 1, 3, 4
• This provides additional protection against pertussis in addition to tetanus and diphtheria 1, 3
• Tdap should be administered regardless of the interval since the last tetanus or diphtheria toxoid-containing vaccine 1

Special Populations Requiring Modified Approach

Pregnant women:

• Use Tdap regardless of prior Tdap history if tetanus prophylaxis is indicated 1, 3

Severely immunocompromised patients (HIV infection, severe immunodeficiency):

• Give TIG 250 units IM regardless of tetanus immunization history when contaminated wounds are present 1, 3, 4
• These patients may not mount adequate antibody responses to vaccine alone 1

Patients with history of Arthus-type hypersensitivity reaction:

• Do not give tetanus toxoid until >10 years after most recent dose, even with contaminated wounds 1, 4
• TIG decision still follows the primary vaccination history algorithm 1

Critical Clinical Pearls and Common Pitfalls

Do not confuse the routine 10-year booster interval with the 5-year interval for contaminated wounds — this is the most common error in tetanus prophylaxis 1

Tetanus toxoid does not protect against the current injury — it takes days to weeks to generate active immunity, so it provides protection against the next injury 5

More frequent doses than recommended increase the risk of Arthus-type hypersensitivity reactions 1

Proper wound cleaning and debridement are as important as vaccination — thorough cleansing markedly reduces tetanus risk 1, 2

Antibiotic chemoprophylaxis is neither practical nor useful for tetanus prevention 1, 2

Do not perform skin testing — intradermal injection of concentrated IgG causes localized inflammation that can be misinterpreted as allergy, potentially leading to withholding needed treatment 2

TIG Administration Details

• Standard prophylactic dose: 250 units IM (non-weight-based for both adults and children) 1, 2
• Human TIG is strongly preferred over equine antitoxin because it provides longer protection and fewer adverse reactions 1
• When TIG supply is limited in mass-casualty settings, prioritize patients >60 years and immigrants from regions outside North America/Europe, as they are least likely to have adequate antibody levels 1

Summary Table for Quick Reference

Prior Doses	Time Since Last	Dirty Wound	Vaccine Needed	TIG Needed
≥3 doses	<5 years	Yes	None	No
≥3 doses	≥5 years	Yes	Tdap (or Td)	No
<3 or unknown	Any	Yes	Tdap	Yes (250 U IM)

1, 2